Abstract

Abstract Two different series of ruthenium complexes, ML 3 and MLL′ 2 where M = Ru(III)/Ru(II), L = ferrocenyl amino acid mannich base conjugates and L′ = 1,10-phenanthroline have been synthesized and characterized by spectroscopic methods. These ferrocenyl ligands and their ruthenium complexes have been investigated for their interactions with DNA and BSA (bovine serum albumin) employing steady-state fluorescence quenching measurements, UV–vis spectroscopy and DNA viscosity measurements. High binding constants obtained from the DNA binding studies ( K b = 10 4 – 10 6 M −1 ) prompted the in-vitro cytotoxicity assay of complexes on A549 human lung carcinoma cells (employing MTT assay). The IC 50 values (within the range of 46 μM–422 μM) obtained herein were found to be lower than those of the well known ruthenium complex NAMI-A currently under phase II clinical trials which has IC 50 values in the range of 550 μM–750 μM for various cancer cell lines. Interaction of these complexes with A549 cells has been further scrutinized using acridine orange (AO)/ethidium bromide (EB) dual staining technique to indicate apoptosis as the mode of cell death.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.